| abstract |
The invention discloses the application of the anticancer effect of dendrobium officinale, and belongs to the technical field of cell biology. This class of compounds is named Dendrocandins and has the following structure: Dendrobium officinale provided by the invention has better biological activity, can target tubulin, thereby inhibiting the growth of tumors, and provides a theoretical basis for dendrobiidin as an antitumor drug. |